Glycos Biotechnologies, Inc. (GlycosBio) is a privately-held industrial biotechnology company enabling the production of key commercial chemicals from a wide range of starting materials. Leveraging GlycosBio’s proprietary microorganisms, companies can flexibly make high-value chemical products from a wide range of industrial and agricultural feedstocks. By directing biomolecules through efficient metabolic pathways, greater production yields are possible surpassing thermochemical conversion. By optimizing the biochemical production of product chemicals from microbial strains, the cost of making chemicals is dramtically reduced. And by diversifying the products and co-products of a plant, greater profitability is possible in climates of stable and unstable commodity prices. The operational model for us is the integrated biorefinery plants that produce fuels alongside chemicals and energy. We partner with companies that have a vested interest in leveraging infrastructure for the production of alternative fuels and chemicals. Biodiesel and ethanol producers, oilseed and oleochemical companies, as well as engineering and design-build firms, all benefit from GlycosBio’s ability to expand feedstock-product value margins.